Pot stocks are full of speculation. This industry went full hype-cycle in 2018, with valuations soaring 1,000% or more. The downturns of 2019 and 2020 scared off many of these overly enthusiastic investors.
But don’t give up! There’s one cannabis producer that has what it takes to generate immense long-term gains.
This is how to profit with cannabis
You can make a lot of money by investing in pot stocks; just don’t think anyone can do it. As last year’s bear market proved, high-upside investments often have high downside, too.
The good news is that we know more than ever which cannabis stocks will rise over the long term. There’s been enough experimentation in the market to give smart investors hard data on what will work and what won’t.
The biggest thing you need to know is this: avoid commoditization!
In early 2019, before the two-year cannabis bear market took hold, I’d warned investors that commoditization was the biggest risk for pot investors.
“While there are some regulatory barriers to growing cannabis, some fail to appreciate that commercial vegetable growers must also jump through large amounts of red tape. If there truly are great profits to be had, expect more and more producers to jump into the market,” I stressed.
If pot supply growth exceeded demand growth, prices would only move lower.
“Today, it’s not very profitable to grow staples like tomatoes, beans, rice, or cabbage. In another decade, there’s a chance that growing cannabis isn’t wildly profitable either. That reality could crush nearly every cannabis stock,” I’d concluded.
The last two years went exactly as predicted, with cannabis stocks struggling under the weight of lower prices via commoditization. Now that the market has bottomed, however, there’s another chance to catch a surging bull market.
This pot stock is ready to rise
Think of HEXO as the Coca-Cola of pot. It deals with a bunch of individual commodities, but it packages and brands those ingredients in a way that produces brand loyalty and sustainably high margins.
“Cannabis is a brand business,” explained the company’s CEO. “We’re not about commodity farming. We’re focused on developing products that offer very specific experiences and are dose-controlled, shelf-stable and delivered to the adult-use market through non-prescription channels.”
For example, the company has a partnership with Molson Coors to sell co-branded, THC-infused beverages in both Canada and the United States. Sales are expected to ramp throughout 2021. The company wants to replicate this partnership in dozens of other categories, including sleep aids and cosmetics.
HEXO understood long ago what the competition is now just figuring out. If you want to make sustainable profits, you need to have a brand consumers trust. That’s why the company skipped straight to partnerships, leveraging brands that customers already know and love.
Right now, HEXO is years ahead of the pot competition. I expect shares to lead the industry higher as investor appetite re-emerges.
HEXO isn't our top pot stock for 2021....
Before you consider Aurora Cannabis, you may want to hear this.
Motley Fool Canadian Chief Investment Advisor, Iain Butler, and his Stock Advisor Canada team just revealed what they believe are the 10 best stocks for investors to buy right now... and Aurora Cannabis wasn't one of them.
The online investing service they've run since 2013, Motley Fool Stock Advisor Canada, has beaten the stock market by over 3X. And right now, they think there are 10 stocks that are better buys.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.
The Motley Fool recommends HEXO. and HEXO. Fool contributor Ryan Vanzo has no position in any stocks mentioned.